Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences